Pathophysiologic therapeutic targets in hypertension: a cardiological point of view

By Fragasso Gabriele   Maranta Francesco   Montanaro Claudia   Salerno Anna   Torlasco Camilla   Margonato Alberto  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 179-193

Informa Healthcare

Access to resources Recommend Favorite

Manidipine for Hypertension not Controlled by Dual Therapy in Patients with Diabetes Mellitus: A Non-Comparative, Open-Label Study

By Martell-Claros Nieves  

Clinical Drug Investigation, Vol. 31, Iss. 6, 2011-06 ,pp. : 427-434

Adis International

Access to resources Recommend Favorite

Comparison of the Efficacy and Tolerability of Combination Tablets Containing Candesartan Cilexetil and Hydrochlorothiazide or Losartan and Hydrochlorothiazide in Patients with Moderate to Severe Hypertension: Results of the CARLOS-Study

By Koenig W.  

Clinical Drug Investigation, Vol. 19, Iss. 4, 2000-04 ,pp. : 239-246

Adis International

Access to resources Recommend Favorite

Adverse Events Associated with Rofecoxib Therapy: Results of a Large Study in Community-Derived Osteoarthritic Patients

By Bannwarth B.  

Drug Safety, Vol. 26, Iss. 1, 2003-01 ,pp. : 49-54

Adis International

Access to resources Recommend Favorite

The Long-Term Effect of Statins on the Risk of New-Onset Diabetes Mellitus in Elderly Taiwanese Patients with Hypertension and Dyslipidaemia: A Retrospective Longitudinal Cohort Study

By Tsochiang  

Drugs & Aging, Vol. 29, Iss. 1, 2012-01 ,pp. : 45-51

Adis International

Access to resources Recommend Favorite